Paliperidone Tablet, Extended Release
Product Images NDC 72162-2649

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Paliperidone (NDC 72162-2649). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Label (Lbl721622649)

Paliperidone Extended-Release Tablets 3 mg oral tablets, packaged in a 30-tablet container. The label shows the NDC 72162-2649-3, with dosing instructions to take once daily, and storage conditions between 20° to 25°C. Relabeled by Bryant Ranch Prepack and manufactured by Eskayef Pharmaceuticals Limited. The label includes QR codes for package insert and prescribing information.*

FDA Label Image

Chemical Structure (Paliperidone 01)

Chemical structure of Paliperidone. The diagram shows the molecular arrangement of atoms and bonds characteristic of the active pharmaceutical ingredient paliperidone, used in extended-release oral tablets.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.